CRISPR corrects DMD in mice for a year in Sarepta-supported study

A Duke lab at the center of a research pact with Sarepta is reporting promising results from a trial of CRISPR gene editing in mouse models of DMD. But the treatment has produced some off-target effects, which the researchers plan to investigate further in future studies.